Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Autor: Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Weijer RJ; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven, the Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, the Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Deventer, the Netherlands., Koene HR; Department of Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal De Ruyter Hospital, Goes, the Netherlands., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1903-1913. Date of Electronic Publication: 2024 Feb 15.

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.

Autor: Chamuleau MED; Department of Hematology, Amsterdam University Medical Center, Location VU, Amsterdam, Netherlands; Cancer Centre Amsterdam, Amsterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands. Electronic address: m.chamuleau@amsterdamumc.nl., Stenner F; Department of Oncology, University Hospital Basel, University of Basel, Basel, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Chitu DA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Novak U; Department of Medical Oncology, Inselspital /Bern University Hospital, Bern, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Geerts P; Department of Hematology, Isala Clinics, Zwolle, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., van Imhoff GW; Department of Hematology, University Medical Center Groningen, Groningen, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Wu KL; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Stuivenberg, Antwerp, Belgium; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Demandt AMP; Division of Hematology, Department of Internal Medicine, School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Terpstra WE; Department of Hematology, Amsterdam-Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Tick LW; Department of Internal Medicine, Máxima Medical Center, Eindhoven, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Deeren D; Department of Hematology, Algemeen Ziekenhuis Delta, Roeselare, Belgium; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Van Den Neste E; Department of Hematology, Cliniques universitaires Université catholique de Louvain Saint-Luc, Belgium., Gregor M; Department of Hematology, Luzerner Kantonsspital, Luzern, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Böhmer LH; Department of Hematology Haga Teaching Hospital, The Hague, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Caspar CB; Department of Internal Medicine, Division of Medical Oncology and Hematology, Kantonsspital Baden, Baden, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Mutsaers P; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Refos JM; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Sewsaran R; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Fu L; Pathology Facility, Amsterdam University Medical Center, Location VU, Amsterdam, Netherlands; Cancer Centre Amsterdam, Amsterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Seefat RL; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Netherlands., Dirnhofer S; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Van Den Brand M; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., de Jong D; Department of Pathology, Amsterdam University Medical Center, Location VU, Amsterdam, Netherlands; Cancer Centre Amsterdam, Amsterdam, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, Netherlands; Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Amsterdam, Netherlands., Lugtenburg P; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2023 Dec; Vol. 10 (12), pp. e966-e975. Date of Electronic Publication: 2023 Oct 31.

Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.

Autor: Lawless S; Belfast City Hospital, Belfast., Iacobelli S; Tor Vergata University, Rome., Knelange NS; EBMT Data Office Leiden, Leiden., Chevallier P; CHU Nantes, Nantes., Blaise D; ICRCM, INSERM, CNRS, AMU and Institut Paoli Calmettes, Marseille., Milpied N; CHU Bordeaux, Pessac., Foà R; Univ.`La Sapienza`, Rome., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam., Lioure B; Nouvel Hopital Civil, Strasbourg., Benjamin R; Kings College Hospital, London., Poiré X; Cliniques Universitaires St. Luc, Brussels., Minnema MC; University Medical Center, Utrecht, Utrecht., Collin M; Freeman Hospital, Newcastle., Lenhoff S; Skanes University Hospital, Lund., Snowden JA; Sheffield Teaching Hospitals Foundation Trust, Sheffield., Santarone S; Ospedale Civile, Pescara., Wilson KMO; University Hospital of Wales, Cardiff Wales., Trigo F; Hospital Sao Joao, Porto., Dreger P; University of Heidelberg, Heidelberg., Böhmer LH; Haga Teaching Hospital The Hague., Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden., Garderet L; Hospital Saint Antoine, Paris., Kröger N; University Hospital Eppendorf, Hamburg., Yaukoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, Lille., Schönland S; University of Heidelberg, Heidelberg. Stefan.Schoenland@med.uni-heidelberg.de., Morris C; Queens University of Belfast, Belfast.

Publikováno v: Haematologica [Haematologica] 2023 Apr 01; Vol. 108 (4), pp. 1105-1114. Date of Electronic Publication: 2023 Apr 01.